• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PiZ型严重遗传性α1-抗胰蛋白酶缺乏症患者的第一秒用力呼气容积下降

Decline in FEV1 among patients with severe hereditary alpha 1-antitrypsin deficiency type PiZ.

作者信息

Seersholm N, Kok-Jensen A, Dirksen A

机构信息

Pulmonary Department P, Bispebjerg Hospital, Copenhagen, Denmark.

出版信息

Am J Respir Crit Care Med. 1995 Dec;152(6 Pt 1):1922-5. doi: 10.1164/ajrccm.152.6.8520756.

DOI:10.1164/ajrccm.152.6.8520756
PMID:8520756
Abstract

Severe alpha 1-antitrypsin (alpha 1-AT) deficiency is characterized by a decrease in serum alpha 1-AT to values < 20% of normal. Severe airflow obstruction, most commonly due to pulmonary emphysema secondary to the destruction of pulmonary elastic tissue, may develop at an early age in persons with alpha 1-AT deficiency. The purpose of this study was to estimate the annual decline in FEV1 (delta FEV1) in alpha 1-AT-deficient patients, to compare delta FEV1 in a referral population (index cases) with subjects found through family studies (nonindex cases), and to evaluate the role of smoking cessation on delta FEV1. One hundred and sixty-one subjects from the Danish alpha 1-AT-deficiency study who were older than 25 yr and who had a recorded smoking history and at least two spirometric examinations 1 yr apart were studied. The delta FEV1 for each individual was determined by regression analysis of FEV1 on follow-up time. The overall mean delta FEV1 was 81 ml/yr. There was no significant difference in delta FEV1 between 113 index cases and 48 nonindex cases even after controlling for age, initial FEV1, sex, and lifetime tobacco consumption. One hundred of the subjects were ex-smokers, 18 had never smoked, and 43 were current smokers. The mean delta FEV1 among the current smokers was 132 ml/yr, versus 52 ml/yr among the ex-smokers (p < 0.001). For the never-smokers, the mean delta FEV1 was 86 ml/yr.

摘要

严重α1-抗胰蛋白酶(α1-AT)缺乏症的特征是血清α1-AT降低至正常水平的<20%。严重气流阻塞最常见于继发于肺弹性组织破坏的肺气肿,可在α1-AT缺乏症患者的早年出现。本研究的目的是估计α1-AT缺乏症患者的第一秒用力呼气容积(FEV1)的年下降率(ΔFEV1),比较转诊人群(索引病例)与通过家族研究发现的受试者(非索引病例)的ΔFEV1,并评估戒烟对ΔFEV1的作用。对来自丹麦α1-AT缺乏症研究的161名年龄超过25岁、有吸烟史记录且至少间隔1年进行过两次肺功能检查的受试者进行了研究。通过对FEV1与随访时间进行回归分析来确定每个个体的ΔFEV1。总体平均ΔFEV1为81 ml/年。即使在控制了年龄、初始FEV1、性别和终生烟草消费量之后,113例索引病例和48例非索引病例之间的ΔFEV1也没有显著差异。其中100名受试者为戒烟者,18名从未吸烟,43名是当前吸烟者。当前吸烟者的平均ΔFEV1为132 ml/年,而戒烟者为52 ml/年(p<0.001)。对于从不吸烟者,平均ΔFEV1为86 ml/年。

相似文献

1
Decline in FEV1 among patients with severe hereditary alpha 1-antitrypsin deficiency type PiZ.PiZ型严重遗传性α1-抗胰蛋白酶缺乏症患者的第一秒用力呼气容积下降
Am J Respir Crit Care Med. 1995 Dec;152(6 Pt 1):1922-5. doi: 10.1164/ajrccm.152.6.8520756.
2
Survival and FEV1 decline in individuals with severe deficiency of alpha1-antitrypsin. The Alpha-1-Antitrypsin Deficiency Registry Study Group.α1-抗胰蛋白酶严重缺乏个体的生存率及第一秒用力呼气量下降情况。α1-抗胰蛋白酶缺乏症注册研究组
Am J Respir Crit Care Med. 1998 Jul;158(1):49-59. doi: 10.1164/ajrccm.158.1.9712017.
3
Decline in FEV1 related to smoking status in individuals with severe alpha1-antitrypsin deficiency (PiZZ).重度α1-抗胰蛋白酶缺乏症(PiZZ型)患者中,第一秒用力呼气容积(FEV1)下降与吸烟状况的关系。
Eur Respir J. 1999 Feb;13(2):247-51. doi: 10.1183/09031936.99.13224799.
4
[Long-term therapy of alpha 1-antitrypsin-deficiency-associated pulmonary emphysema with human alpha 1-antitrypsin].用人α1-抗胰蛋白酶对α1-抗胰蛋白酶缺乏相关的肺气肿进行长期治疗
Pneumologie. 1998 Oct;52(10):545-52.
5
Survival in relation to lung function and smoking cessation in patients with severe hereditary alpha 1-antitrypsin deficiency.严重遗传性α1-抗胰蛋白酶缺乏症患者的生存与肺功能及戒烟的关系
Am J Respir Crit Care Med. 1995 Feb;151(2 Pt 1):369-73. doi: 10.1164/ajrccm.151.2.7842193.
6
Aspects of treatment in alpha 1-antitrypsin deficiency: insights derived from a Swedish PiZZ series.α1-抗胰蛋白酶缺乏症的治疗方面:来自瑞典PiZZ队列的见解
Eur Respir J Suppl. 1990 Mar;9:39s-43s.
7
Decline in pulmonary function in patients with alpha 1-antitrypsin deficiency.α1-抗胰蛋白酶缺乏症患者的肺功能下降。
Lung. 1990;168 Suppl:579-85. doi: 10.1007/BF02718180.
8
Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis.重度早发性慢性阻塞性肺疾病的遗传流行病学。亲属患气流阻塞和慢性支气管炎的风险。
Am J Respir Crit Care Med. 1998 Jun;157(6 Pt 1):1770-8. doi: 10.1164/ajrccm.157.6.9706014.
9
Decline in FEV and hospitalized exacerbations in individuals with severe alpha-1 antitrypsin deficiency.严重的α-1 抗胰蛋白酶缺乏症个体的 FEV 下降和住院加重。
Int J Chron Obstruct Pulmon Dis. 2019 May 23;14:1075-1083. doi: 10.2147/COPD.S195847. eCollection 2019.
10
Deficient alpha-1-antitrypsin phenotypes and persistent airflow limitation in severe asthma.严重哮喘中α-1-抗胰蛋白酶表型缺乏与持续性气流受限
Respir Med. 2006 Sep;100(9):1534-9. doi: 10.1016/j.rmed.2006.01.009. Epub 2006 Feb 14.

引用本文的文献

1
Plasma levels of α-antitrypsin-derived C-terminal peptides in PiMM and PiZZ COPD patients.PiMM和PiZZ型慢性阻塞性肺疾病患者血浆中α-抗胰蛋白酶衍生的C末端肽水平。
ERJ Open Res. 2023 Dec 4;9(6). doi: 10.1183/23120541.00329-2023. eCollection 2023 Nov.
2
Lung Inflammation in alpha-1-antitrypsin deficient individuals with normal lung function.α1-抗胰蛋白酶缺乏个体的肺部炎症,肺功能正常。
Respir Res. 2023 Feb 2;24(1):40. doi: 10.1186/s12931-023-02343-3.
3
Why is Disease Penetration so Variable in Alpha-1 Antitrypsin Deficiency? The Contribution of Environmental Factors.
为何α-1抗胰蛋白酶缺乏症的疾病穿透率如此多变?环境因素的作用
Chronic Obstr Pulm Dis. 2020 Jul;7(3):280-289. doi: 10.15326/jcopdf.7.3.2019.0177.
4
Decline in FEV and hospitalized exacerbations in individuals with severe alpha-1 antitrypsin deficiency.严重的α-1 抗胰蛋白酶缺乏症个体的 FEV 下降和住院加重。
Int J Chron Obstruct Pulmon Dis. 2019 May 23;14:1075-1083. doi: 10.2147/COPD.S195847. eCollection 2019.
5
Advances in managing COPD related to α -antitrypsin deficiency: An under-recognized genetic disorder.α-抗胰蛋白酶缺乏症相关 COPD 的治疗进展:一种被低估的遗传性疾病。
Allergy. 2018 Nov;73(11):2110-2121. doi: 10.1111/all.13558. Epub 2018 Jul 26.
6
Gene and miRNA expression profiles in PBMCs from patients with severe and mild emphysema and PiZZ alpha1-antitrypsin deficiency.严重和轻度肺气肿以及 PiZZ 型α1-抗胰蛋白酶缺乏症患者 PBMCs 中的基因和 miRNA 表达谱。
Int J Chron Obstruct Pulmon Dis. 2017 Nov 29;12:3381-3390. doi: 10.2147/COPD.S145445. eCollection 2017.
7
Clinical utility of alpha-1 proteinase inhibitor in the management of adult patients with severe alpha-1 antitrypsin deficiency: a review of the current literature.α-1蛋白酶抑制剂在成年重症α-1抗胰蛋白酶缺乏症患者管理中的临床应用:当前文献综述
Drug Des Devel Ther. 2017 Jul 14;11:2149-2162. doi: 10.2147/DDDT.S105207. eCollection 2017.
8
Z α1-antitrypsin confers a proinflammatory phenotype that contributes to chronic obstructive pulmonary disease.α1-抗胰蛋白酶赋予一种促炎表型,这对慢性阻塞性肺疾病有影响。
Am J Respir Crit Care Med. 2014 Apr 15;189(8):909-31. doi: 10.1164/rccm.201308-1458OC.
9
Alpha1-antitrypsin deficiency: a clinical-genetic overview.α1-抗胰蛋白酶缺乏症:临床遗传学概述。
Appl Clin Genet. 2011 Mar 31;4:55-65. doi: 10.2147/TACG.S10604. Print 2011.
10
α1-Proteinase inhibitor (human) in the treatment of hereditary emphysema secondary to α1-antitrypsin deficiency: number and costs of years of life gained.α1-蛋白酶抑制剂(人)治疗α1-抗胰蛋白酶缺乏症继发遗传性肺气肿:获得的寿命年数和成本。
Clin Drug Investig. 2012 May 1;32(5):353-60. doi: 10.2165/11631920-000000000-00000.